NEW YORK, Oct. 17 - GeneFormatics has raised $22 million in its third round of financing, the structural proteomics company announced on Wednesday.

Investors supporting the round comprised Bruker AXS, Bruker BioSpin, Bruker Daltonics, TaKaRa Shuzo, and China Development Industrial Bank. They joined earlier investors Perseus-Soros BioPharmaceutical Fund, Merrill Lynch Ventures, Orbimed Advisors, Burrill & Co., GeneChem, Inglewood Ventures, and Moss Forest Venture, GeneFormatics said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.